Metal Complexes in Target‐Specific Anticancer Therapy: Recent Trends and Challenges

G Shumi, T Desalegn, TB Demissie… - Journal of …, 2022 - Wiley Online Library
Cancer is characterized by abnormal cell differentiation in or on the part of the body. The
most commonly used chemotherapeutic drugs are developed to target rapidly dividing cells …

14-3-3 protein and its isoforms: A common diagnostic marker for Alzheimer's disease, Parkinson's disease and glaucomatous neurodegeneration

SP Panda, A Kesharwani, B Singh, AL Marisetti… - Ageing Research …, 2024 - Elsevier
There is a molecular coupling between neurodegenerative diseases, including
glaucomatous neurodegeneration (GN), Alzheimer's disease (AD), and Parkinson's disease …

Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening

V Kumar, PKC Lakshman, TK Prasad, K Manjunath… - Heliyon, 2024 - cell.com
Target-based discovery of first-in-class therapeutics demands an in-depth understanding of
the molecular mechanisms underlying human diseases. Precise measurements of cellular …

14-3-3 promotes sarcolemmal expression of cardiac CaV1.2 and nucleates isoproterenol-triggered channel superclustering

HC Spooner, AD Costa, M Westhoff… - Proceedings of the …, 2025 - pnas.org
The L-type Ca2+ channel (CaV1. 2) is essential for cardiac excitation–contraction coupling.
To contribute to the inward Ca2+ flux that drives Ca2+-induced-Ca2+-release, CaV1. 2 …

Structure of a 14-3-3ε:FOXO3apS253 Phosphopeptide Complex Reveals 14-3-3 Isoform-Specific Binding of Forkhead Box Class O Transcription Factor (FOXO) …

S Mathivanan, PK Chunchagatta Lakshman… - Acs Omega, 2022 - ACS Publications
The transcriptional activity of Forkhead Box O3 (FOXO3a) is inactivated by AKT-mediated
phosphorylation on Serine 253 (S253), which enables FOXO3a binding to 14-3-3 …

FOXO3a-interacting proteins' involvement in cancer: A review

Z Dong, Z Guo, H Li, D Han, W **e, S Cui… - Molecular Biology …, 2024 - Springer
Due to its role in apoptosis, differentiation, cell cycle arrest, and DNA damage repair in
stress responses (oxidative stress, hypoxia, chemotherapeutic drugs, and UV irradiation or …

SH‐PRO extract alleviates benign prostatic hyperplasia via ROS‐mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in …

JE Park, WC Shin, HJ Lee, D Yoon… - Phytotherapy …, 2023 - Wiley Online Library
To target benign prostatic hyperplasia (BPH) as a common urinary disease in old men, in the
current study, the antiproliferative and apoptotic mechanism of SH‐PRO, a mixture of …

From mechanisms of carcinogenesis to early intervention: an interview with Ashok Venkitaraman

A Venkitaraman - Disease Models & Mechanisms, 2024 - journals.biologists.com
Ashok Venkitaraman has made seminal discoveries elucidating the tumour suppressive
mechanisms that maintain genome integrity through his pivotal studies on the breast cancer …